Lu Zhou > Hogan Lovells International LLP > Chaoyang District, China > Lawyer Profile

Leveraging its lawyers’ experience as government officials in regulatory and policy agencies, Hogan Lovells International LLP‘s Greater China life sciences practice is consistently sought out to for complex regulatory issues. The team advises at all stages of life sciences products, from initial clinical trials to off-patent strategy, business development and defence-side litigation The team also advises on new technology-driven areas, such as digital health, AI, gene therapy and regenerative medicine. On the mainland, Lu Zhou advises life sciences and healthcare clients on cross-border transactions; and Calvin Ding represents companies (and their board committees) in relation to corruption, conflicts of interest, trade compliance and cybersecurity incidents. Jessie Xie‘s practice covers regulatory work and commercial contracts in the pharmaceutical, medical devices, healthcare, food, and cosmetics sectors.

Representing leading multinational and Chinese clients across the mining, TMT, and life sciences fields, Hogan Lovells International LLP handles the full spectrum of corporate transactions, with a particular focus on cross-border M&A and restructurings. The practice includes a team of practitioners who advise on regulatory compliance and employment matters, while the Beijing-based head Liang Xu specialises in distressed M&A and special situations. Lu Zhou primarily concentrates on strategic business transactions, while in Shanghai, Don Williams has vast experience of acting for corporate ventures and private equity funds, and Tony Mou is a fund formation and corporate finance expert.

Hogan Lovells International LLP‘s China practice routinely leverages the firm’s enviable global network of private equity practitioners across Asia, Europe, Latin America, Africa, and the Middle East and US for cross-jurisdictional mandates. It is particularly focused on the technology and biotechnology sectors, in relation to both high-value and mid-cap matters. In Shanghai, Don Williams is a highly-rated private equity and technology industry specialist; and Tony Mou acts for private equity and venture capital funds, as well as general and limited partners, entrepreneurs, and venture-backed growth stage and public companies. Over in Beijing, Lu Zhou advises multinational corporations, corporate ventures and private equity fund clients on cross-border transactions. Stephanie Tang heads the Greater China private equity group from Hong Kong.